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Background: The purpose of this study was to devise a novel electrochemical immunosensor 
for ultrasensitive detection of alfa-fetoprotein based on Fe3O4/Au nanoparticles as a carrier 
using a multienzyme amplification strategy.
Methods and results: Greatly enhanced sensitivity was achieved using bioconjugates 
containing horseradish peroxidase (HRP) and a secondary antibody (Ab2) linked to Fe3O4/Au 
nanoparticles (Fe3O4/Au-HRP-Ab2) at a high HRP/Ab2 ratio. After a sandwich immunoreaction, 
the Fe3O4/Au-HRP-Ab2 captured on the electrode surface produced an amplified electrocatalytic 
response by reduction of enzymatically oxidized hydroquinone in the presence of hydrogen 
peroxide. The high content of HRP in the Fe3O4/Au-HRP-Ab2 could greatly amplify the 
  electrochemical signal. Under optimal conditions, the reduction current increased with increasing 
alfa-fetoprotein concentration in the sample, and exhibited a dynamic range of 0.005–10 ng/mL 
with a detection limit of 3 pg/mL.
Conclusion: The amplified immunoassay developed in this work shows good precision, accept-
able stability, and reproducibility, and can be used for detection of alfa-fetoprotein in real samples, 
so provides a potential alternative tool for detection of protein in the laboratory. Furthermore, 
this immunosensor could be regenerated by simply using an external magnetic field.
Keywords: Fe3O4/Au nanoparticles, alfa-fetoprotein, sandwich immunoassay, electrochemical 
immunosensor
Introduction
It is well known that alfa-fetoprotein (AFP), an oncofetal glycoprotein with a molecu-
lar weight of approximately 70,000 Da, is a tumor marker that occurs mainly in 
hepatocellular carcinoma, yolk sac tumors, and the serum of patients with other malig-
nant tumors.1–3 The average concentration of AFP in healthy human serum is ,20 ng/mL, 
and serum AFP levels often increase in a number of disease states.4 Therefore, detec-
tion of trace amounts of AFP is of great importance. Thus far, various immunosensors 
and immunoassays based on different measurement principles have been reported 
for determination of AFP, including enzyme-linked immunosorbent assay (ELISA),5 
electrochemiluninescence,6,7 chemiluminescence,8,9 surface plasmon resonance10,11 and 
quartz crystal microbalance.12,13 ELISA is the most widely used immunoassay method 
in the laboratory. However, concentrations of tumor-related proteins are very low in 
the early stages of cancer, and are beyond the detection limit of ELISA. Moreover, 
their lengthy analysis requires highly skilled personnel, specially equipped laborato-
ries, and expensive reagents.14 Thus, new methods that can rapidly and conveniently 
monitor tumor-related proteins are highly desirable. Electrochemical immunosensors, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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based on specificity of antigen–antibody interactions with 
electrochemical transducers, have attracted considerable 
interest because of their intrinsic advantages, such as low 
cost, high sensitivity, simple instrumentation, and excellent 
compatibility with miniaturization technologies.15   Therefore, 
different electrochemical immunosensors, particularly 
amperometric immunosensors, have been developed and 
applied extensively for the determination of AFP.16–18
In order to meet the increasing demand for early and 
ultrasensitive detection of tumor markers, three primary 
  signal amplification strategies using nanomaterials have 
been developed.19 The first method involves the use 
of metal and semiconductor nanoparticles directly as 
  electroactive labels to amplify the electrochemical detection 
of proteins.20,21 The second method uses nanoparticles as 
carriers for   loading a large amount of electroactive species 
to amplify the   detection signal.22,23 The third method is the 
most extensively employed, and uses enzyme-functionalized 
nanoparticles as labels. Enhanced sensitivity was achieved 
by loading a large amount of enzyme towards an individual 
sandwich immunological reaction event. Recently, various 
types of nanomaterials have been used as carriers for loading 
enzymes and antibodies to enhance sensitivity, including 
gold nanoparticles,24 irregularly shaped gold nanoparticles,25 
nanosilica particles,26 carbon nanoparticles,27,28 carbon 
nanotubes,29 and graphene oxide.30 For example, Chen 
et al have proposed a highly sensitive electrochemical 
immunosensor using irregular gold nanoparticles as   carriers 
of horseradish peroxidase (HRP)-anti-AFP for signal 
amplification.25 Similarly, Lin et al have reported use of 
  graphene oxide, a novel tracer, to label HRP and the anti-
body, and developed an ultrasensitive immunoassay method 
for detection of phosphorylated p53 (S392).30
Recently, hybrid nanomaterials consisting of two or 
more different nanoscale functionalities have attracted much 
attention due to their novel combined properties and mul-
tiple potential applications.31 Immunomagnetic beads in 
particular are widely used in enrichment and separation of 
particular proteins in biology samples.32–34 Among them, 
magnetic composite Fe3O4/Au nanoparticles have attracted 
particular attention, owing to the combined functions of 
Fe3O4 and gold. Fe3O4 nanoparticles have a typical super-
paramagnetic nature, and provide a convenient means for 
separation, isolation, and purification of biological samples 
via an external magnetic field when the functional reagents 
are attached onto the surface of the particles.35,36 Their 
unique structural, electronic, and optical properties make 
gold nanoparticles very attractive for several applications 
in biotechnology.37–39   Further, gold nanoparticles can provide 
a natural environment for bimolecular immobilization and 
facilitate electron transfer of biosensors because of their 
large surface area, interesting electrochemical properties, and 
good biocompatibility.40–42 Therefore, magnetic composite 
Fe3O4/Au nanoparticles have had more and more applica-
tions in areas such as immunoassays, protein immobilization, 
cell purification, and magnetically controlled transport of 
anticancer drugs.43–46
Our present work focuses on enzyme-enriched, magnetic 
functionalized nanoparticles in signal amplification and 
  separation for ultrasensitive detection of AFP. Magnetic 
composite Fe3O4/Au nanoparticles were synthesized by 
assembling gold nanoparticles on SH-modified Fe3O4 and 
using them as nanocarriers for immobilization of HRP and 
a secondary antibody (Ab2). Greatly amplified sensitivity 
is achieved using bioconjugates featuring HRP and Ab2 
linked to Fe3O4/Au at a high HRP/Ab2 ratio for replacement 
of   singly labeled secondary antibodies. A modified glass 
carbon   electrode with porous nanostructured gold film was 
used to attach the primary antibody (Ab1). The analytical 
procedure consists of immunoreaction of the antigen (AFP) 
with Ab1, followed by binding of Fe3O4/Au-HRP-Ab2. 
Electrochemical detection was performed in the presence 
of H2O2 and hydroquinone (Figure 1). The results demon-
strated that an immunosensor based on this amplification 
strategy has a good dynamic range from 0.005 to 10 ng/mL 
and a low detection limit of 3 pg/mL for AFP. This simple, 
cost-effective, and sensitive immunosensor could find wide 
potential application in clinical analysis.
Materials and methods
reagents and materials
Monoclonal  mouse  antihuman AFP  and AFP  test 
kits were obtained from Zhengzhou Biocell Biochem 
  Company (Zhengzhou, China). Fe3O4 (20 nm in diameter), 
3-  mercaptopropyltriethoxysilane (3-MPTES) and HRP 
(EC 1.11.1.7, RZ . 3.0, A . 250 U/mg) were purchased 
from Sigma-Aldrich, St Louis, MO. Hydrogen tetrachlo-
roaurate (III) tetrahydrate (HAuCl4⋅4H2O), trisodium 
citrate,   hydroquinone, H2O2, and bovine serum albumin 
were obtained from Sinopharm Group Chemical Reagent 
Company Ltd (Shanghai, China). All reagents used were 
of analytical reagent grade, and all solutions were prepared 
with double deionized water. Phosphate-buffered solutions 
0.1 M of various pH values were prepared by mixing stock 
solutions of NaH2PO4 and Na2HPO4, and then the pH was 
adjusted with 0.1 M NaOH and H3PO4.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3261
Magnetic nanoparticle amplification for AFP immunoassay
Apparatus
Cyclic voltammetry measurements were performed using 
an electrochemical analyzer CHI 660 (Shanghai Chenhua 
Instrumental Corp, China) connected to a personal com-
puter. A three-compartment electrochemical cell contained 
a platinum wire auxiliary electrode, a saturated calomel 
reference electrode, and a modified glass carbon electrode 
(GCE, 2 mm in diameter) as working electrode. The sizes 
of the nanoparticles were estimated from transmission 
electron microscopy (H-7650, Hitachi Instruments, Tokyo, 
Japan). The surface topographic features and composition 
of variously modified electrodes were characterized using 
scanning electron microscopy coupled with energy disper-
sive spectroscopy (SEM-EDS, S3400N Hitachi). The x-ray 
powder diffraction images were obtained using a Bruker 
D8 Advance diffractometer (Bruker, Karlsruhe, Germany). 
Ultraviolet-visible spectra were recorded using a TU-1901 
spectrophotometer (Purkinje General Instrument Co, Beijing, 
China). The x-ray photoelectron spectra were taken using an 
AXIS UltraDLD spectrometer (Shimadzu Co, Tokyo, Japan). 
Vibrating sample magnetometry (Lake Shore 7410) was used 
to perform magnetic measurements on the dried samples to 
evaluate the magnetic properties of the nanoparticles.
Preparation of Fe3O4/Au nanoparticles
Figure 1A shows the procedure used to prepare the Fe3O4/Au. 
First, gold nanoparticles was prepared using the Frens 
  method.47 In brief, 0.01 wt% HAuCl4 (100 mL) was boiled 
with vigorous stirring in a flask. Trisodium citrate 1 wt% 
solution (2.5 mL) was added quickly to the boiling solution, 
resulting in a color change from pale yellow to dark red, 
indicating formation of gold nanoparticles. The solution was 
maintained for 10 minutes at boiling temperature.
Fe3O4/Au nanoparticles were obtained by self-assembling 
gold nanoparticles onto the surface of SH-modified Fe3O4 
according to the literature with modification.48 Fe3O4 nano-
particles are commercially available. Experimentally, Fe3O4 
0.2 g was dispersed in 50% ethanol 90 mL by ultrasound, and 
then 3-MPTES 300 µL and ammonium hydroxide 500 µL 
were added dropwise. The mixture was stirred at 60°C for 
6 hours under a nitrogen atmosphere. Uncoated Fe3O4 was 
deleted by means of washing with 0.1 M HCl (six times, for 
four hours each). The deposit was separated by a magnetic 
stirrer, which was rinsed three times with double deionized 
water and then ethanol to give SH-modified Fe3O4. Following 
that, the gold nanoparticles were added to the SH-modified Fe3O4, 
and shaken slightly for 4 hours at room temperature to make the 
gold assemble on the surface of the formed   nanoparticles. After 
magnetic separation, the Fe3O4/Au obtained were rinsed with 
double deionized water and suspended in 10 mL water.
Preparation of Fe3O4/Au-hrP-Ab2 
conjugates
Figure 1B shows the procedure used to prepare the Fe3O4/
Au-HRP-Ab2 bioconjugate. Initially, 1.0 mL of a 1.0 mg/mL 
Fe3O4/Au nanoparticle suspension was adjusted to pH 8.2 
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Figure 1 schematic representation of the preparation of (A) Fe3O4/Au, (B) Fe3O4/Au-hrP-Ab2, and (C) immunosensor.
Abbreviations: AFP, alfa-fetoprotein; BsA, bovine serum albumin; hrP, horseradish peroxidase; Ab2, secondary antibody.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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using Na2CO3. Thereafter, 200 µL of HRP at 1 mg/mL and 
200 µL of Ab2 at 10 µg/mL were added to the dispersion, 
and the mixture was stirred overnight at 4°C. After magnetic 
separation and washing three times, the resulting mixture was 
redispersed in 1.0 mL of pH 7.4 phosphate-buffered solution 
containing 1% bovine serum albumin and stored at 4°C.
Fabrication of the immunosensor
The procedure followed to prepare the proposed immunosen-
sor is schematized in Figure 1C. The GCE was polished with 
0.3 µm and 0.05 µm alumina, followed by successive sonica-
tion in distilled water and ethanol for 5 minutes and dried 
in air. A porous nanostructure gold film was then deposited 
at a voltage of −0.5 V for 50 seconds on the clean GCE that 
was immersed in 5 mL 0.08 M HAuCl4 solution containing 
0.004 M lead acetate. After thorough washing with water, 
the electrode was immediately followed by incubation 
with 20 µL 0.5 mg/mL Ab1 for one hour. After washing 
with 0.05% Tween-20 and phosphate-buffered solution, 
Ab1/Au/GCE was incubated in 3% bovine serum albumin 
and   phosphate-buffered solution at 37°C for one hour to 
block excess active groups and nonspecific binding sites 
on the   surface. The electrode was then washed with 0.05% 
Tween-20 and phosphate-buffered solution before use.
Immunoassay procedure for detection  
of AFP
A sandwich immunoassay was used for determination of 
AFP. The immunosensor, Ab1/Au/GCE, was incubated 
with 20 µL of a different concentration of standard AFP 
antigen for 30 minutes at 25°C, followed by washing with 
0.05% Tween-20 and phosphate-buffered solution. Next, the 
electrode was incubated with 20 µL of Fe3O4/Au-HRP-Ab2 
for 30 minutes at 25°C, followed by washing with 0.05% 
Tween-20 and phosphate-buffered solution to remove the 
nonspecific adsorption of conjugate. Electrochemical detec-
tion was performed in 5 mL of pH 6.5 phosphate-buffered 
solution containing 2 mM hydroquinone and 5 mM H2O2, 
and from −0.6 to 0.6 V (versus saturated calomel reference 
electrode) with a scan rate of 100 mV/second.
Results and discussion
characterization of Fe3O4/Au-hrP-Ab2 
conjugation
In this work, Fe3O4/Au was as an excellent carrier for HRP and 
Ab2 because of its good biocompatibility, large surface area, 
and superparamagnetic properties. Transmission electron 
microscope images provide more detailed morphological 
information on the prepared nanoparticles (Figure 2). They 
demonstrated that both Fe3O4 and Fe3O4/Au nanoparticles 
were spherical in structure, monodispersed, and of appropri-
ate size. The average diameter of the Fe3O4/Au nanoparticles 
was about 40 nm (Figure 2C). Upon deposition of gold 
onto the Fe3O4 nanoparticles, the diameter of the particles 
increased by about 20 nm, demonstrating that the thickness 
of the gold was about 10 nm.
Figure 3A compares the x-ray powder diffraction pattern 
for the Fe3O4 nanoparticles and Fe3O4/Au nanoparticles. 
In Figure 3A (curve a), the diffraction peak positions at 
2θ = 30.0°, 35.3°, 42.6°, 53.4°, and 62.5° can be attributed 
to the (220), (311), (400), (422), (511), and (440) planes of 
Fe3O4 in a cubic phase (space group Fd3 m), respectively. 
In Figure 3A (curve b), the diffraction peak positions at 
2θ = 38.1°, 44.2°, 64.5°, 77.5°, and 81.6° can be attributed to 
the (111), (200), (220), (311), and (222) planes, respectively. 
Other peaks can be attributed to Fe3O4, and the simultaneous 
observation of both Fe3O4 and gold peaks verified successful 
assembly of Fe3O4/Au nanoparticles.
The surface composition of elements such as iron and 
gold in the Fe3O4/Au nanoparticles were determined by x-ray 
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photoelectron spectra as shown in Figure 3B. Figure 3B 
shows gold peaks including Au 4s, Au 4p, Au 4d, and Au 4f 
appearing on the surface of the Fe3O4 nanoparticles. The Au 
4f appearing at 80–90 eV can be assigned to the Au0. The 
Fe3O4 showed Fe 2p at 700–720 eV . The x-ray photoelectron 
spectra result was in agreement with a report by Cui et al 
indicating that gold had been successfully assembled on the 
surface of the magnetic Fe3O4 nanoparticles.48
The magnetic properties of the nanoparticles are illustrated 
in Figure 4. It can be seen that a small coercivity or remanence 
existed around room temperature, indicating the Fe3O4 and 
Fe3O4/Au have superparamagnetic   properties. As a result, the 
Fe3O4/Au could be isolated from solution by an adscititious 
magnet. It can also be seen that the   saturation magnetiza-
tion for Fe3O4/Au is much smaller than that for Fe3O4. 
The saturation magnetization values were 76.8 emu/g and   
54.9 emu/g for Fe3O4 and Fe3O4/Au nanoparticles, respectively. 
The saturation magnetization value of the magnetic nano-
particles declined after coating with a layer of gold. This 
lower saturation magnetization value is due to the presence 
of nonmagnetic gold.
The Fe3O4/Au-HRP-Ab2 obtained was characterized by 
ultraviolet-visible spectroscopy and, as shown in Figure 5, 
the Fe3O4 nanoparticles did not show any obvious absorbance 
peaks in ultraviolet-visible spectroscopy (curve a).   However, 
the Fe3O4/Au nanoparticles showed a clear absorption band 
containing a maximum centered at 540 nm (curve c). This 
band showed a red shift in comparison with pure gold nano-
particles (curve b, 520 nm). This finding suggests that a 
combination of Fe3O4 nanoparticles and gold nanocomposites 
leads to a red shift of resonant wavelength. After Ab2 and HRP 
were conjugated onto the Fe3O4/Au, two absorption peaks 
around 280 nm and 404 nm were observed (curve f), which 
can be ascribed to the typical absorption of Ab2 (curve d) 
and HRP (curve e).
seM-eDs characterization of gold 
nanoparticles modified electrode  
with direct electroposition
SEM-EDS were used to investigate the successful fabrica-
tion of the immunosensor. Figure 6A shows the energy 
dispersive spectroscopy analysis of Au/GCE showing 
Au-M (2.0 keV), Au-Lα (9.7 keV), and Au-Lβ (11.4 keV), 
which indicates successful electrodeposition of gold on the 
GCE.   Furthermore, scanning electron microscopy was used 
to investigate the Au/GCE before and after modification 
with Ab1. As shown in Figure 6B, many small porous gold 
nanoparticles were obtained on the Au/GCE. Obviously, the 
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porous gold film-modified electrode had a larger surface 
compared with the ordinary glassy carbon electrode, which 
could provide a larger surface area for the immobilization 
of Ab1. Upon immobilization of Ab1, obvious aggregation of 
the trapped biomolecules could be observed on the surface 
(Figure 6C), indicating successful immobilization of Ab1.
electrochemical characterization  
of the immunosensor
As shown in Figure 7, the cyclic voltammograms of Ab1/Au/
GCE did not show any detectable signal in pH 6.5 phosphate-
buffered solution (curve a). Upon adding 2 mM hydroquinone 
and 5 mM H2O2 to the phosphate-buffered solution, Ab1/Au/
GCE exhibited a pair of stable and well defined redox peaks 
at −145 mV and 345 mV (curve b), corresponding to the 
electrochemical redox response of hydroquinone on the elec-
trode surface. When incubating the immunosensor with 5 ng/
mL AFP antigen, no obvious change in signal was observed. 
However, after incubation with Fe3O4/Au-HRP-Ab2, the 
resulting sandwich immunocomplex displayed an   obvious 
increase in electrocatalytic reduction current (curve c) 
because of the introduction of HRP onto the electrode surface 
by the immunoreaction.
comparison of detection antibodies  
with various labels
To investigate further the effect of the synthesized Fe3O4/Au 
on the sensitivity of the electrochemical immunosensors, 
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three types of detection antibodies were used, ie, HRP-
  anti-Ab2, Au-HRP-Ab2, and Fe3O4/Au-HRP-Ab2   ( Figure 8). 
As shown in Figure 8A–C, upon addition of H2O2 to the 
substrate solution, an obvious catalytic characteristic 
appeared, with a distinct increase in the reduction current 
and a decrease in the oxidation current. The catalytic current 
is mainly due to the labeled HRP toward the reduction of 
H2O2 with the help of hydroquinone as an electron mediator. 
As shown in Figure 8, we found that the electrochemical 
immunosensor exhibited a larger current shift using Au-
HRP-Ab2 (Figure 8B) as the detection antibody than when 
using HRP-anti-Ab2 (Figure 8A). The reason for this might 
be that the gold nanoparticles with a high surface-to-volume 
ratio and good biocompatibility can load more HRP and Ab2. 
Moreover, gold nanoparticles have good conductivity, 
which can enhance enzyme activity.49 More significantly, 
the electrochemical responses could be improved by using 
Fe3O4/Au-HRP-Ab2 (Figure 8C) rather than Au-HRP-Ab2 
(Figure 8B). A possible reason is that Fe3O4 can allow more 
room for attachment of gold nanoparticles, which indirectly 
increases the amount of bound Ab2 and HRP. When one 
antibody molecule on the surface of Fe3O4/Au-HRP-Ab2 is 
reacted with the corresponding antigen, other HRP molecules 
can enter and participate in the electrochemical reaction. At 
the same time, Fe3O4/Au can enhance the electron transfer 
rate between the enzyme and the electrode.50,51
Optimization of immunoassay conditions
Because of the coimmobilization of enzymes and antibodies 
on the Fe3O4/Au nanocarrier, the ratio of HRP and Ab2 is 
the most important factor in the response signal. As shown 
in Figure 9A, one can see that the electrocatalytic current 
increases with an increasing ratio of HRP/Ab2, and the maxi-
mum response is achieved at a ratio of 100:1. An increase in 
the HRP/Ab2 ratio could increase the total amount of HRP 
loaded per Fe3O4/Au nanocarrier, which would be expected 
to increase the response amplification for this sandwich 
immunoassay. However, reducing the amount of Ab2 in the 
immunoassay may decrease the efficiency of the immune 
reaction to the AFP antigen captured at the electrode surface, 
which may result in a decreased response. Therefore, an 
HRP/Ab2 ratio of 100:1 was selected as the optimal condition 
in which to prepare the Fe3O4/Au-HRP-Ab2 conjugate. To 
determine the amount of active HRP in the Fe3O4/Au-HRP-
Ab2 conjugate dispersion, the mixture was reacted with the 
TMB substrate for HRP. The reaction product was read at 
650 nm. These results were compared with a standard curve 
constructed using pure HRP as part of an enzyme activity 
experiment. The concentration of active HRP in the Fe3O4/
Au-HRP-Ab2 conjugate dispersion was determined to be 
7.14 µg/mL.
The pH of the detection solution is an important param-
eter because the acidity of the solution is greatly affected 
by the activity of immobilized proteins. The effect of pH 
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toward 5 ng/mL alfa-fetoprotein in the absence (A) and presence (B) of 5 mM h2O2 
in an electrolytic cell in phosphate-buffered solution containing 2 mM hydroquinone 
by  using  various  detection  antibodies  (a)  hrP-anti-Ab2,  (b)  Au-hrP-Ab2,  and 
(C) Fe3O4/Au-hrP-Ab2.
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of the solution on the amperometric response for AFP is 
shown in Figure 9B. The current response was increased by 
increments in pH from 4.0 to 6.5 and then decreased when 
pH exceeded 6.5. Therefore, a 0.1 M solution of pH 6.5 was 
selected as the optimum solution for AFP detection.
The temperature and time taken for the antigen-antibody 
interaction to occur greatly influenced the sensitivity of the 
sandwich-type immunoassay developed. Considering the 
practical applications of the proposed system in clinical 
immunoassays, all experiments were carried out at room 
temperature (25°C ± 1.0°C). Under this condition, the 
effect of various incubation times (10–45 minutes) on the 
immunosensor current was investigated at 1 mg/mL of AFP. 
As shown in Figure 9C, the reduction current increased 
with increasing incubation time and tended to level off after 
30 minutes, indicating optimal formation of the sandwich-
type immunocomplexes. A longer incubation time could not 
improve the response. Therefore, 30 minutes of incubation 
time was used for the detection of AFP in this study.
Analytical performance
The cyclic voltammograms of the immunosensor was 
investigated by assaying various AFP standards using 
Fe3O4/Au-HRP-Ab2 as trace labels and H2O2 as the enzyme 
substrate. The reduction current increased with incremental 
AFP concentration in the incubation solution. As shown 
by curve a in Figure 10, the increase in reduction current 
was proportional to AFP concentration in the range 
of 0.005–10 ng/mL; the linear regression equation is 
∆ip(µA) = 13.3 × logCAFP (ng/mL) + 42.2 with a detection 
limit of 3 pg/mL (R2 = 0.988). For comparison, we also 
investigated the analytical performance of the immunosensor 
using Au-HRP-Ab2 and HRP-anti-AFP as detection 
antibodies, respectively. The regression equations, linear 
ranges, and detection limits are as follows:
Using Au-HRP-Ab2 (Figure 9 curve b):  
   ∆ip(µA) = 5.88 × logCAFP (ng/mL) + 13.0,  
R2 = 0.990, 0.01–10 ng/mL, 6 pg/mL AFP  (i)
Using HRP-anti-AFP (Figure 9 curve c):  
   ∆ip(µA) = 3.51 × logCAFP (ng/mL) + 3.88,  
R2 = 0.962, 1.0–10 ng/mL, 0.6 ng/mL AFP  (ii)
These results suggest that Fe3O4/Au could greatly improve 
the sensitivity and work range of the immunosensor. Although 
the threshold of human serum AFP is 10 ng/mL, actual serum 
samples should be diluted during the clinical diagnostic   process, 
so the concentrations detected are usually ,10 ng/mL. Small 
volume samples are preferable. Thus, the sensitivity of this 
immunoassay was adequate for practical application.
Regeneration of immunosensors is of great interest to 
  immunoanalysts. Traditional regeneration of the immunosensor 
usually requires a different regeneration solution, such as an 
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acid, alkali, or electrolyte solution at a high concentration to 
break the linkage between the antigen and antibody. In the 
present work, the immunosensor could be regenerated by 
simply using an external magnetic field to remove the Fe3O4/
Au-HRP-Ab2-bonded antigen.   Experimental results indicated 
that the immunosensor could retain 90.7% of the initial current 
response for 18 applications once regenerated.
Immunosensor specificity, reproducibility, 
and stability
Specificity is an important feature of the immunosensor. To 
investigate this, the immunosensor was incubated with 1 ng/mL 
AFP containing a different interference substance, such as 
carcinoma antigen 125, carcinoembryonic antigen, human 
IgG, prostate-specific antigen, and bovine serum albumin. No 
remarkable change of currents was observed in comparison 
with the results obtained in the presence of AFP only, indicating 
good selectivity of the proposed AFP immunosensor.
The reproducibility of the proposed immunosensor 
was evaluated by intra-assay and interassay coefficients of 
variation. The intra-assay precision of the analytical method 
was evaluated by analyzing one immunosensor for six 
replicate determinations. Coefficients of variation for the 
intra-assay were 3.6% and 4.7% at 0.1 ng/mL and 1.0 ng/mL 
AFP, respectively. Similarly, the interassay coefficients 
of variation for six immunosensor determinations were 
3.9% and 5.5% at 0.1 ng/mL and 1.0 ng/mL AFP,   respectively. 
These results demonstrate the acceptable reproducibility and 
precision of the proposed immunosensor.
We also examined the stability of the developed 
  immunosensor. When not in use, the immunosensor could 
be stored in pH 7.0 phosphate-buffered solution at 4°C for at 
least 3 weeks without any obvious signal change. Moreover, 
the immunosensor retained 89.4% of its initial response after 
a storage period of 4 weeks. The slow decrease in current 
response may be attributed to gradual deactivation of biomol-
ecules immobilized on the nanoparticle surface.
Application of the immunosensor  
in human serum
The electrochemical immunosensor was further   validated by 
assaying six serum specimens gifted from the   Nanfang Medical 
Hospital, China. The serum was prepared by collecting whole 
blood, leaving it undisturbed for 15–30 minutes at room tem-
perature to clot, and then removing the clot by centrifugation 
at 1000–2000 rpm for 10 minutes in a refrigerated centrifuge, 
and collecting the supernatant serum. Table 1 describes 
the correlation between the partial results obtained by the International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3268
Gan et al
  proposed immunosensor and the ELISA method, indicating 
no significant difference between the two methods, ie, the 
proposed immunosensor could be used for satisfactory clinical 
determination of AFP levels in human serum.
Conclusion
We have successfully designed a multienzyme labeling 
Fe3O4/Au strategy as part of a signal amplification procedure 
and demonstrated its use in the ultrasensitive, selective, and 
accurate quantification of AFP by electrochemical immunoas-
say. Highlights of the developed immunoassay are: Fe3O4/Au 
as the enzyme-loading carrier can load many enzyme mol-
ecules on each Fe3O4/Au nanoparticle, thus enhancing the 
sensitivity of the immunosensor; using Fe3O4/Au as signal 
enhancers favors rapid separation and purification of the sig-
nal antibody on an external magnetic field; after each detec-
tion, the immunosensor can be easily regenerated by applying 
an external magnetic field. The proposed immunosensor has 
high sensitivity, good reproducibility, stability, and accuracy. 
We anticipate that this method can be extended for deter-
mination of other proteins and have promising potential in 
clinical applications.
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